✦ LIBER ✦

Febuxostat (TMX‐67), a Novel, Non‐Purine, Selective Inhibitor of Xanthine Oxidase, Is Safe and Decreases Serum Urate in Healthy Volunteers

✍ Scribed by Becker, M. A.; Kisicki, J.; Khosravan, R.; Wu, J.; Mulford, D.; Hunt, B.; MacDonald, P.; Joseph‐Ridge, N.

Book ID: 126556746
Publisher: Taylor and Francis Group
Year: 2004
Tongue: English
Weight: 146 KB
Volume: 23
Category: Article
ISSN: 0732-8311
DOI: 10.1081/NCN-200027372

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Febuxostat (TMX-67), a Novel, Non-Purine

Febuxostat (TMX-67), a Novel, Non-Purine, Selective Inhibitor of Xanthine Oxidase, Is Safe and Decreases Serum Urate in Healthy Volunteers

✍ M. A. Becker; J. Kisicki; R. Khosravan; J. Wu; D. Mulford; B. Hunt; P. MacDonald 📂 Article 📅 2005 🏛 John Wiley and Sons ⚖ 8 KB 👁 1 views

## Abstract For Abstract see ChemInform Abstract in Full Text.

Pharmacokinetics and Pharmacodynamics of

Pharmacokinetics and Pharmacodynamics of Febuxostat (TMX‐67), a Non‐Purine Selective Inhibitor of Xanthine Oxidase/Xanthine Dehydrogenase (NPSIXO) in Patients with Gout and/or Hyperuricemia

✍ Komoriya, K.; Hoshide, S.; Takeda, K.; Kobayashi, H.; Kubo, J.; Tsuchimoto, M.; 📂 Article 📅 2004 🏛 Taylor and Francis Group 🌐 English ⚖ 97 KB

Pharmacokinetics and Pharmacodynamics of

Pharmacokinetics and Pharmacodynamics of Febuxostat (TMX-67), a Non-Purine Selective Inhibitor of Xanthine Oxidase/Xanthine Dehydrogenase (NPSIXO) in Patients with Gout and/or Hyperuricemia

✍ K. Komoriya; S. Hoshide; K. Takeda; H. Kobayashi; J. Kubo; M. Tsuchimoto; T. Nak 📂 Article 📅 2005 🏛 John Wiley and Sons ⚖ 9 KB 👁 1 views

Pharmacokinetics, Pharmacodynamics and S

Pharmacokinetics, Pharmacodynamics and Safety of Febuxostat, a Non-Purine Selective Inhibitor of Xanthine Oxidase, in a Dose Escalation Study in Healthy Subjects

✍ Dr Reza Khosravan, Brian A. Grabowski, Jing-Tao Wu, Nancy Joseph-Ridge, Laurent 📂 Article 📅 2006 🏛 Springer International Publishing AG 🌐 English ⚖ 268 KB

In vitro drug–drug interaction studies w

In vitro drug–drug interaction studies with febuxostat, a novel non-purine selective inhibitor of xanthine oxidase: plasma protein binding, identification of metabolic enzymes and cytochrome P450 inhibition

✍ Mukoyoshi, M.; Nishimura, S.; Hoshide, S.; Umeda, S.; Kanou, M.; Taniguchi, K.; 📂 Article 📅 2008 🏛 Informa plc 🌐 English ⚖ 161 KB